Skip to content
In English |
En español
National Cancer Institute
at the National Institutes of Health
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
Email This Document
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
LiveHelp online chat
Popular Resources
Help Using the NCI Clinical Trials Search Form
Learn About Clinical Trials
About NCI's List of Cancer Clinical Trials
NCI Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-16 of 16 for your search:
Drug:
piperazinedione
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III PZD and Total Body Irradiation Followed by Allogeneic Bone Marrow Transplantation and Prophylactic MTX for Acute Leukemia in Remission
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
NCI-D81-043-078
, MDA-DT-7970
2.
Phase I-II Chemotherapy with CTX, ADR, DAG, VP-16, PZD and TZT for Solid Tumors
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
Protocol IDs:
MAYO-750302
3.
Phase II Chemotherapy with PZD for Refractory Sarcomas and Malignant Melanomas
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
SEG-76MSAR0102
, SEG-76MSAR206
4.
Phase II Chemotherapy with CTX/DTIC vs CTX/DTIC/Piperazinedione for Metastatic Melanoma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
SEG-77MEL0102
, SEG-77MEL212
5.
Phase II Chemotherapy with Piperazinedione in Acute Childhood Leukemia and Solid Tumors
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
under 18
Sponsor:
Protocol IDs:
SJCRH-PIPER-2
6.
Phase II Autologous Stem Cell Transplantation & PZD Chemotherapy plus Radiotherapy for Adult Acute Leukemia in Complete Remission and Chronic Phase Chronic Granulocytic Leukemia
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 to 50
Sponsor:
Protocol IDs:
MDA-DT-7524
, NCI-D78-043-184
7.
Phase II Chemotherapy with Piperazinedione for a Wide Spectrum of Incurable Refractory Solid Tumors
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
16 to 80
Sponsor:
Protocol IDs:
CENOG-7522
8.
Phase II Trials of 13 Additional Chemotherapeutic Agents, Alone or Combined for non-Small Cell Lung Cancer
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
EST-2575-II
9.
Phase II Chemotherapy with Piperazinedione for Advanced Gynecologic Malignancies in Women
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
GOG-26B
10.
Phase II Chemotherapy with CTX, ADR, VP-16, VCR, cis-Platinum, PZD, TZT and DAG for Solid Tumors
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
MAYO-750305
11.
Chemotherapy with Piperazinedione for Refractory Lymphoma or Multiple Myeloma
Phase:
No phase specified
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
SWOG-7435
12.
Chemotherapy with Piperazinedione for Advanced Metastatic Breast Carcinoma
Phase:
No phase specified
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
SWOG-7508
13.
Phase II-III Chemotherapy with PZD, L-PAM, MTX, ICRF-159, ACT-D, YOSHI 864, or CCNU for Advanced Large Bowel Cancer
Phase:
No phase specified
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
EST-1277
14.
Chemotherapy with CTX, ADR, VCR, VP-16, cis-Platinum, TZT, PZD and DTIC plus Radiotherapy for Small Cell Lung Cancer
Phase:
No phase specified
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
MAYO-762001
15.
Chemotherapy with Piperazinedione for Blast Transformation of Chronic Myelogenous Leukemia
Phase:
No phase specified
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
MDA-DT-7566
16.
Allogeneic Stem Cell Transplantation & PZD Chemotherapy & Radiotherapy for Adult Acute Leukemia
Phase:
No phase specified
Type:
Treatment
Status:
Closed
Age:
50 and under
Sponsor:
Protocol IDs:
MDA-DT-7559
Select All on Page
Help with Results
We Can Answer Your Questions
1-800-4-CANCER
LiveHelp Online Chat
NCI Home
Contact Us
Policies
Accessibility
Viewing Files
FOIA
Site Help
Site Map
Other Versions of this Site:
Mobile
|
Español
Follow Us:
Twitter
YouTube
Facebook
RSS
NIH…Turning Discovery Into Health
®